CRWD vs JNJ: Which Is the Better Buy?
Side-by-side comparison of CrowdStrike Holdings, Inc. and Johnson & Johnson β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-24.
CrowdStrike Holdings, Inc. Β· Technology
$436.32
+34.6% upside to fair value
Grade B
VS
Johnson & Johnson Β· Healthcare
$230.69
+10.8% upside to fair value
Grade C
High Quality
QuantHub Verdict
CRWD has more upside to fair value
(+34.6%).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
CRWD |
JNJ |
| Current Price |
$436.32 |
$230.69 |
| Fair Value Estimate |
$587.16 |
$255.61 |
| Upside to Fair Value |
+34.6%
|
+10.8%
|
| Market Cap |
$110.7B |
$555.9B |
| Forward P/E |
-601.6x
|
26.8x
|
| EV / EBITDA |
951.5x
|
18.5x
|
| Price / Sales |
23.0x
|
5.8x
|
| Price / FCF |
89.3x
|
28.2x
|
| Revenue Growth YoY |
+23.3%
|
+9.9%
|
| Gross Margin |
74.9%
|
69.1%
|
| Operating Margin |
-5.4%
|
26.9%
|
| Return on Equity |
-4.7%
|
26.5%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.12%
|
3.54%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-based endpoint protection and threat intelligence, with a dominant subscription revenue model accounting for over 95% of total revenue. The business quality is medium due to strong revenue growth of 23.3% in the most recent quarter and a robust earnings growth of 141.9% in the same period, supported by a high grosβ¦
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,β¦
Accumulation Zones
| Metric |
CRWD |
JNJ |
| Zone Low |
$440.37 |
$191.71 |
| Zone High |
$499.09 |
$217.27 |
| In Buy Zone? |
Yes
|
No
|